Lee Flowers Biography and Net Worth

SVP of HCW Biologics

Lee Flowers has served as our Senior Vice President of Business Development since September 2019. Prior to joining our company, Mr. Flowers served as Executive Vice President of Dade International, a spin-off of Baxter International Inc., from 1994 to 1996; the Vice President of Venture Development at Baxter Diagnostics, Baxter International Inc.’s largest subsidiary, from 1993 to 1994; and Division President at Baxter Diagnostics from 1991 to 1993. Upon the merger between American Hospital Supply Corporation and Baxter International Inc.’s predecessor, Mr. Flowers served as the Vice President of Global Marketing for the Dade Division in 1990 and Vice President, Sales and Marketing for the Paramax Systems Division from 1986 to1989 at the merged entity. Mr. Flowers received his bachelor’s degree in biology from the University of Kentucky.

What is Lee Flowers' net worth?: The estimated net worth of Lee Flowers is at least $14.12 thousand as of July 29th, 2026. Flowers owns 8,691 shares of HCW Biologics stock worth more than $14,123 as of October 9th. This net worth approximation does not reflect any other investments that Flowers may own. Learn More about Lee Flowers' net worth.
How do I contact Lee Flowers?: The corporate mailing address for Flowers and other HCW Biologics executives is 2929 N Commerce Pkwy, Miramar, FL, 33025. HCW Biologics can also be reached via phone at 954-842-2024 and via email at [email protected]. Learn More on Lee Flowers' contact information.
Has Lee Flowers been buying or selling shares of HCW Biologics?: Lee Flowers has not been actively trading shares of HCW Biologics over the course of the past ninety days. Most recently, on Wednesday, July 29th, Lee Flowers bought 7,736 shares of HCW Biologics stock. The stock was acquired at an average cost of $2.58 per share, with a total value of $19,958.88. Following the completion of the transaction, the senior vice president now directly owns 8,691 shares of the company's stock, valued at $22,422.78. Learn More on Lee Flowers' trading history.
Who are HCW Biologics' active insiders?: HCW Biologics' insider roster includes Lee Flowers (SVP), and Jin-An Jiao (VP). Learn More on HCW Biologics' active insiders.
Are insiders buying or selling shares of HCW Biologics?: During the last year, HCW Biologics insiders bought shares 4 times. They purchased a total of 47,500 shares worth more than $310,874.64. The most recent insider tranaction occured on July, 29th when SVP Lee Flowers bought 7,736 shares worth more than $19,958.88. Insiders at HCW Biologics own 9.1% of the company. Learn More about insider trades at HCW Biologics.
Information on this page was last updated on 7/29/2026.

Lee Flowers Insider Trading History at HCW Biologics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/29/2026	Buy	7,736	$2.58	$19,958.88	8,691
5/8/2025	Buy	160	$156.00	$24,960.00	953
6/8/2023	Buy	41	$518.40	$21,254.40	463

Lee Flowers Buying and Selling Activity at HCW Biologics

HCW Biologics Company Overview

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Today's Range

Now: $1.72

$1.52

$1.73

50 Day Range

MA: $2.48

$1.53

$3.60

2 Week Range

Now: $1.72

$1.50

$27.57

Volume

40,229 shs

Average Volume

1,247,081 shs

Market Capitalization

$3.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.41